N02BA11 - Diflunisal |
Not porphyrinogenic |
NP |
Rationale
No oxidative phase in its metabolism. Four references: safe/use/use.
Chemical description
Analgesic; anti-inflammatory salisylate analogue. Eliminated in urine as glucuronide conjugate.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | Australian List
Australian Porphyria Association No longer maintained
|
|
| 2. | French List
Centre Français des Porphyries
|
|
| 3. | EPI List
European Porphyria Initiative No longer maintained
|
|
| 4. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames
Attrogy 
Attrogy 
Attrogy 
Attrogy 
Attrogy 
Diflunisal · Dolobid · Novo-Diflunisal 
Diflunisal · Donobid · Extempore N02BA11 Diflunisal 
Diflunisal 
Dolobid 
Attrogy 
Attrogy 
Attrogy 
Attrogy 
Attrogy 
Attrogy 
Diflunisal · Dolobid 
Diflunisal